Mae gwaith yr Ystorfa Feddyginiaethau wedi dechrau drwy gaffael platfform (ar sail prawf o gysyniad) a allai fod yn sail iddi. Bydd asesiad llawn o dechnolegau posibl yn cael ei gynnal yn ystod yr haf eleni, cyn i’r tîm symud ymlaen â’r gwaith o ddatblygu’r fersiwn derfynol o’r Ystorfa Feddyginiaethau. Bydd yr ystorfa yn seiliedig ar safonau agored y diwydiant ar ddata sy’n golygu y bydd unrhyw blatfform yn gallu rhannu data â hi. Yn ogystal, bydd yr ystorfa yn cael data o blatfformau eraill sy’n rhoi presgripsiynau sy’n cael eu defnyddio ledled GIG Cymru, er enghraifft y system Uned Gofal Dwys Digidol a’r cynllun Cyfnewid Systemau Gwybodaeth am Ganser. Mae gan y rhain swyddogaethau arbenigol iawn o ran rhoi presgripsiynau ond bydd y data hynny ar gael er mwyn galluogi i glinigwyr i wneud penderfyniadau wedi’u hysbysu’n llawn am feddyginiaethau wrth ystyried sut i drin cleifion.
The Medicines Repository work has started with the procurement (on a proof-of-concept basis) of a platform which could underpin it. A full assessment of potential technologies will take place this summer before the team progress with building the final version of the Medicines repository. The repository will be based on industry open standards for data, which means that any platform will be able to share data with it. The repository will also receive data from other prescribing platforms in use across NHS Wales, such as the Digital Intensive Care Unit system and the Cancer Information Systems Replacement, both of which have highly specialised prescribing functionality– but that data will be available to allow clinicians to make a fully informed medication decision when considering how to treat a patient.